Paracelsian AndroVir "supports normal immune function" in HIV patients -- preliminary data.
This article was originally published in The Tan Sheet
Executive Summary
PARACELSIAN ANDROVIR "SUPPORTS NORMAL IMMUNE FUNCTION" IN HIV PATIENTS, according to preliminary results of a nine-week Phase I trial of 16 patients released by the Ithaca, N.Y.-based company. "The design of this trial was to introduce increasingly larger amounts of AndroVir in relatively short periods of time," Paracelsian said. "The effect on HIV-1 viral load and CD4 cells demonstrated in this clinical study indicates that AndroVir supports normal immune function."